Bio-Thera Solutions, Ltd. (SHA:688177)
China flag China · Delayed Price · Currency is CNY
22.44
-0.18 (-0.80%)
At close: Mar 9, 2026

Bio-Thera Solutions Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
9,2929,5828,02517,0779,01910,696
Upgrade
Market Cap Growth
12.54%19.40%-53.01%89.35%-15.68%-18.77%
Upgrade
Enterprise Value
9,6749,9648,27616,9058,0619,624
Upgrade
Last Close Price
22.4423.1419.3841.2421.7825.83
Upgrade
PE Ratio
-----130.54
Upgrade
PS Ratio
9.9510.2610.8024.2319.8212.79
Upgrade
PB Ratio
19.1919.7911.3314.085.615.12
Upgrade
P/TBV Ratio
35.1236.2216.5817.386.575.79
Upgrade
P/FCF Ratio
-----67.53
Upgrade
P/OCF Ratio
-----45.27
Upgrade
EV/Sales Ratio
10.3610.6711.1423.9917.7111.50
Upgrade
EV/EBITDA Ratio
-----88.40
Upgrade
EV/EBIT Ratio
-----248.38
Upgrade
EV/FCF Ratio
-----60.77
Upgrade
Debt / Equity Ratio
1.341.340.890.400.010.02
Upgrade
Debt / EBITDA Ratio
-----0.29
Upgrade
Debt / FCF Ratio
-----0.21
Upgrade
Net Debt / Equity Ratio
0.790.790.35-0.01-0.49-0.68
Upgrade
Net Debt / EBITDA Ratio
-1.35-1.35-0.550.031.75-13.02
Upgrade
Net Debt / FCF Ratio
---1.360.021.17-8.95
Upgrade
Asset Turnover
--0.330.320.190.33
Upgrade
Inventory Turnover
--0.950.991.520.53
Upgrade
Quick Ratio
--0.450.891.652.96
Upgrade
Current Ratio
--0.811.392.163.37
Upgrade
Return on Equity (ROE)
-56.44%-56.44%-53.13%-27.98%-26.00%4.00%
Upgrade
Return on Assets (ROA)
---15.00%-13.01%-13.79%0.97%
Upgrade
Return on Invested Capital (ROIC)
-42.57%-40.47%-49.98%-46.00%-71.01%4.86%
Upgrade
Return on Capital Employed (ROCE)
---48.60%-29.80%-32.20%1.90%
Upgrade
Earnings Yield
-3.62%-3.51%-6.36%-2.31%-5.33%0.77%
Upgrade
FCF Yield
---2.27%-4.23%-7.45%1.48%
Upgrade
Payout Ratio
-----0.68%
Upgrade
Buyback Yield / Dilution
-0.11%-0.11%0.10%-0.28%-1.09%-1.38%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.